Skip to content
Top Alliance
Next generation biopharmaceuticals
Top Alliance
  • Home
  • Our Company
    • Our History
    • Our Leadership
    • Our Commitment
  • What we do
    • Discovery
    • Research & Development
    • Manufacturing
  • Our Research
    • Pipeline
    • COVID-19
  • TUOYI®
  • Expanded Access Policy
  • Media
    • News Releases
    • Scientific Publications
    • Company Publications
  • Careers
  • Contact
  • Home
  • Our Company
    • Our History
    • Our Leadership
    • Our Commitment
  • What we do
    • Discovery
    • Research & Development
    • Manufacturing
  • Our Research
    • Pipeline
    • COVID-19
  • TUOYI®
  • Expanded Access Policy
  • Media
    • News Releases
    • Scientific Publications
    • Company Publications
  • Careers
  • Contact

Daily Archives: July 12, 2020

You are here:
  1. Home
  2. 2020
  3. July
  4. 12
Jul122020

Junshi Biosciences Announces Completion of Enrollment in Phase I Trial of SARS-CoV-2 Neutralizing Antibody JS016

NewsJuly 12, 2020

Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus.

Read more
  • TopAlliance Biosciences Inc
© TOPALLIANCE BIOSCIENCES - 2023. All rights reserved.

company.info@topalliancebio.com

Go to Top